Literature DB >> 30135313

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

Matthew J Hartwell, Umut Özbek, Ernst Holler, Anne S Renteria, Hannah Major-Monfried, Pavan Reddy, Mina Aziz, William J Hogan, Francis Ayuk, Yvonne A Efebera, Elizabeth O Hexner, Udomsak Bunworasate, Muna Qayed, Rainer Ordemann, Matthias Wölfl, Stephan Mielke, Attaphol Pawarode, Yi-Bin Chen, Steven Devine, Andrew C Harris, Madan Jagasia, Carrie L Kitko, Mark R Litzow, Nicolaus Kröger, Franco Locatelli, George Morales, Ryotaro Nakamura, Ran Reshef, Wolf Rösler, Daniela Weber, Kitsada Wudhikarn, Gregory A Yanik, John E Levine, James Lm Ferrara.   

Abstract

Entities:  

Year:  2018        PMID： 30135313      PMCID： PMC6141176          DOI： 10.1172/jci.insight.124015

Source DB:  PubMed          Journal:  JCI Insight        ISSN： 2379-3708


× No keyword cloud information.
  9 in total

1.  FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.

Authors:  Donna Przepiorka; Lola Luo; Sriram Subramaniam; Junshan Qiu; Ramadevi Gudi; Lea C Cunningham; Lei Nie; Ruby Leong; Lian Ma; Christopher Sheth; Albert Deisseroth; Kirsten B Goldberg; Gideon M Blumenthal; Richard Pazdur
Journal:  Oncologist       Date:  2019-10-22

2.  A distinct glycerophospholipid metabolism signature of acute graft versus host disease with predictive value.

Authors:  Yue Liu; Aijie Huang; Qi Chen; Xiaofei Chen; Yang Fei; Xiaoming Zhao; Weiping Zhang; Zhanying Hong; Zhenyu Zhu; Jianmin Yang; Yifeng Chai; Jianmin Wang; Xiaoxia Hu
Journal:  JCI Insight       Date:  2019-07-25

3.  Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature.

Authors:  Rodney Macedo; Chloé Pasin; Alex Ganetsky; David Harle; Ximi K Wang; Kirubel Belay; Lee P Richman; Austin P Huffman; Robert H Vonderheide; Andrew J Yates; David L Porter; Ying Wang; Yi Zhang; Ran Reshef
Journal:  Transplant Cell Ther       Date:  2021-09-28

4.  Donor T-cell-derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract.

Authors:  Kate H Gartlan; Motoko Koyama; Katie E Lineburg; Karshing Chang; Kathleen S Ensbey; Rachel D Kuns; Andrea S Henden; Luke D Samson; Andrew D Clouston; Angel F Lopez; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Blood Adv       Date:  2019-10-08

5.  FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.

Authors:  Donna Przepiorka; Lola Luo; Sriram Subramaniam; Junshan Qiu; Ramadevi Gudi; Lea C Cunningham; Lei Nie; Ruby Leong; Lian Ma; Christopher Sheth; Albert Deisseroth; Kirsten B Goldberg; Gideon M Blumenthal; Richard Pazdur
Journal:  Oncologist       Date:  2019-10-22

6.  Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide.

Authors:  Raffaella Greco; Francesca Lorentino; Rosamaria Nitti; Maria Teresa Lupo Stanghellini; Fabio Giglio; Daniela Clerici; Elisabetta Xue; Lorenzo Lazzari; Simona Piemontese; Sara Mastaglio; Andrea Assanelli; Sarah Marktel; Consuelo Corti; Massimo Bernardi; Fabio Ciceri; Jacopo Peccatori
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

Review 7.  Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?

Authors:  Martino Introna; Josée Golay
Journal:  Front Immunol       Date:  2020-12-11       Impact factor: 7.561

8.  The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation.

Authors:  Sook-Kyoung Heo; Eui-Kyu Noh; Yoo Jin Lee; Yerang Shin; Youjin Kim; Hyeon-Su Im; Hyeyeong Kim; Su Jin Koh; Young Joo Min; Jae-Cheol Jo; Yunsuk Choi
Journal:  BMC Cancer       Date:  2022-09-20       Impact factor: 4.638

9.  Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Authors:  Elifcan Aladağ Karakulak; Haluk Demİroğlu; Umit Yavuz Malkan; Umit Akman; Hakan Göker; Yahya Büyükaşik
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.